Asperger Syndrome Global Clinical Trials Review, H2, 2012



Summary



GlobalData's clinical trial report, “Asperger Syndrome Global Clinical Trials Review, H2, 2012" provides data on the Asperger Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Asperger Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Asperger Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Table of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Asperger Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Asperger Syndrome 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Asperger Syndrome Therapeutics Clinical Trials 27
Prominent Drug Comparison 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Forest Laboratories, Inc. 29
Clinical Trial Overview of Forest Laboratories, Inc. 29
SymTrend Inc. 30
Clinical Trial Overview of SymTrend Inc. 30
Johnson and Johnson 31
Clinical Trial Overview of Johnson and Johnson 31
Clinical Trial Overview of Top Universities / Institutes / Hospitals 32
The University of South Florida 32
Clinical Trial Overview of The University of South Florida 32
Indiana University School of Medicine 33
Clinical Trial Overview of Indiana University School of Medicine 33
Cambridge Health Alliance 34
Clinical Trial Overview of Cambridge Health Alliance 34
Isfahan University of Medical Sciences 35
Clinical Trial Overview of Isfahan University of Medical Sciences 35
Yale University 36
Clinical Trial Overview of Yale University 36
Yellen and Associates 37
Clinical Trial Overview of Yellen and Associates 37
Indiana University 38
Clinical Trial Overview of Indiana University 38
Mount Sinai School of Medicine 39
Clinical Trial Overview of Mount Sinai School of Medicine 39
Children's Hospital Boston 40
Clinical Trial Overview of Children's Hospital Boston 40
The University of North Carolina 41
Clinical Trial Overview of The University of North Carolina 41
The University of Mississippi Medical Center 42
Clinical Trial Overview of The University of Mississippi Medical Center 42
University Hospital Freiburg 43
Clinical Trial Overview of University Hospital Freiburg 43
Montefiore Medical Center 44
Clinical Trial Overview of Montefiore Medical Center 44
Kyoto University 45
Clinical Trial Overview of Kyoto University 45
Federal University of Sao Paulo 46
Clinical Trial Overview of Federal University of Sao Paulo 46
University of Florida 47
Clinical Trial Overview of University of Florida 47
Penn State University 48
Clinical Trial Overview of Penn State University 48
University of Rochester 49
Clinical Trial Overview of University of Rochester 49
University of Arkansas 50
Clinical Trial Overview of University of Arkansas 50
Johns Hopkins University 51
Clinical Trial Overview of Johns Hopkins University 51
Five Key Clinical Profiles 52
Appendix 69
Abbreviations 69
Definitions 69
Research Methodology 70
Secondary Research 70
About GlobalData 71
Contact Us 71
Disclaimer 71
Source 72

List of Tables

List of Tables
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Asperger Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Asperger Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Asperger Syndrome Therapeutics Clinical Trials, Europe, Top Countries, 2012* 11
Asperger Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Asperger Syndrome Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 13
Asperger Syndrome Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 14
Asperger Syndrome Therapeutics Clinical Trials, BRIC Countries, 2012* 15
Asperger Syndrome Therapeutics Clinical Trials, G7 Countries, 2012* 16
Asperger Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Asperger Syndrome Therapeutics Clinical Trials, E7 Countries, 2012* 18
Asperger Syndrome Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 19
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Phase, 2012* 20
Asperger Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 21
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Asperger Syndrome Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 23
Asperger Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
Asperger Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 26
Asperger Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
Asperger Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2012* 29
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by SymTrend Inc., 2012* 30
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2012* 31
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2012* 32
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2012* 33
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge Health Alliance, 2012* 34
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Isfahan University of Medical Sciences, 2012* 35
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2012* 36
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Yellen and Associates, 2012* 37
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2012* 38
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 39
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2012* 40
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of North Carolina, 2012* 41
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Mississippi Medical Center, 2012* 42
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Freiburg, 2012* 43
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Montefiore Medical Center, 2012* 44
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2012* 45
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 46
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 47
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2012* 48
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2012* 49
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2012* 50
Asperger Syndrome Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 51

List of Figures

List of Figures
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Asperger Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Asperger Syndrome Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 11
Asperger Syndrome Therapeutics Clinical Trials, G7 Countries (%), 2012* 16
Asperger Syndrome Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 17
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 20
Asperger Syndrome Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 21
Asperger Syndrome Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 22
Asperger Syndrome Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 24
Asperger Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Asperger Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 27
Asperger Syndrome Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 28
GlobalData Methodology 70

Companies Mentioned

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Enabling Technological Platforms for Lab-on-Chip Applications  (Technical Insights)

Enabling Technological Platforms for Lab-on-Chip Applications (Technical Insights)

  • $ 6 500
  • Industry report
  • June 2014
  • by Frost & Sullivan

6 Dimensional Assessment of Lab on a Chip Innovation Landscape A growing trend towards miniaturizing laboratory practices has been a major driving force behind the steady increase of innovations in the ...

Global Proteomics Market

Global Proteomics Market

  • $ 4 950
  • Industry report
  • May 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of ...

Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 201

Label-Free Detection Market by Technology (Bio-layer interferometry, Optical waveguide grating technology, Surface Plasmon resonance), Consumables & Instruments, Applications (Lead Generation, Binding Kinetics), End user - Global Forecasts & Trends to 201

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

Label-free technology is rapidly gaining widespread acceptance as a drug discovery and life science research tool. Currently, the drug discovery process is based on target identification and screening ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.